Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule

Journal of Molecular Biology
Mikaela FriedmanStefan Ståhl

Abstract

The epidermal growth factor receptor 1 (EGFR) is overexpressed in various malignancies and is associated with a poor patient prognosis. A small, receptor-specific, high-affinity imaging agent would be a useful tool in diagnosing malignant tumors and in deciding upon treatment and assessing the response to treatment. We describe here the affinity maturation procedure for the generation of Affibody molecules binding with high affinity and specificity to EGFR. A library for affinity maturation was constructed by rerandomization of selected positions after the alignment of first-generation binding variants. New binders were selected with phage display technology, using a single oligonucleotide in a single-library effort, and the best second-generation binders had an approximately 30-fold improvement in affinity (K(d)=5-10 nM) for the soluble extracellular domain of EGFR in biospecific interaction analysis using Biacore. The dissociation equilibrium constant, K(d), was also determined for the Affibody with highest affinity using EGFR-expressing A431 cells in flow cytometric analysis (K(d)=2.8 nM). A retained high specificity for EGFR was verified by a dot blot assay showing staining only of EGFR proteins among a panel of serum prote...Continue Reading

References

Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
May 15, 1994·International Journal of Cancer. Journal International Du Cancer·G SauterF Waldman
Jan 1, 1996·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·A Cuartero-PlazaF X Real
May 7, 1999·Immunotechnology : an International Journal of Immunological Engineering·M HanssonP A Nygren
Jul 15, 1999·The International Journal of Biochemistry & Cell Biology·A Wells
Feb 11, 2000·Toxicologic Pathology·P Kleihues, H Ohgaki
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Sep 12, 2001·Neuro-oncology·P Kleihues, H Ohgaki
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonM E Harper
Sep 25, 2003·Cancer Biotherapy & Radiopharmaceuticals·Asa Liljegren SundbergVladimir Tolmachev
Jul 21, 2004·Journal of Immunological Methods·Per-Ake Nygren, Arne Skerra
Apr 21, 2005·BJU International·Truls GårdmarkPer-Uno Malmström
Aug 2, 2005·Trends in Biotechnology·Thomas HeyMarkus Fiedler
Sep 10, 2005·Nature Biotechnology·Philipp Holliger, Peter J Hudson
Oct 8, 2005·Nature Biotechnology·H Kaspar BinzAndreas Plückthun
Jan 10, 2006·Cancer Biotherapy & Radiopharmaceuticals·Eva HorakJames D Marks
Apr 19, 2006·Cancer Research·Anna OrlovaFredrik Y Nilsson
Sep 12, 2006·Journal of Molecular Biology·Béatrice LuginbühlAndreas Plückthun
Nov 8, 2006·Journal of Biotechnology·Caroline GrönwallNina Herne
Dec 6, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Torun EngfeldtVladimir Tolmachev
Mar 3, 2007·Bioconjugate Chemistry·Thuy TranAmelie Eriksson Karlström
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Andrew M ScottLloyd J Old
Mar 22, 2007·Expert Opinion on Biological Therapy·Vladimir TolmachevLars Abrahmsén
May 1, 2007·Journal of Molecular Biology·Christian ZahndAndreas Plückthun
Jun 15, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Torun EngfeldtVladimir Tolmachev
Jul 3, 2007·Journal of Biotechnology·Achim RotheBarbara E Power
Jul 20, 2007·Biotechnology Journal·Caroline GrönwallStefan Ståhl

❮ Previous
Next ❯

Citations

Sep 23, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Anna OrlovaVladimir Tolmachev
Mar 17, 2010·Amino Acids·Xin LinXiaoyuan Chen
May 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Scott C DavisBrian W Pogue
Dec 24, 2010·Protein Engineering, Design & Selection : PEDS·Nina KronqvistJohn Löfblom
Sep 21, 2013·Protein Engineering, Design & Selection : PEDS·Hiromichi OkuraTsuyoshi Takahashi
Oct 15, 2013·International Journal of Nanomedicine·Fei-Fei TengJin-Ming Yu
Mar 14, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Anna OrlovaJohn Löfblom
May 3, 2014·Biomaterials·Dongwook KimRihe Liu
Mar 16, 2012·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Susan HoppmannZhen Cheng
Mar 17, 2012·Nuclear Medicine and Biology·Min-Hee JeongJunho Chung
Nov 1, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·S Rahima BenhabbourRussell J Mumper
Aug 3, 2010·Journal of Virological Methods·Bin MuXiyun Yan
Mar 17, 2010·Journal of Molecular Biology·Joachim FeldwischLars Abrahmsén
Jun 9, 2009·Current Opinion in Chemical Biology·Michaela Gebauer, Arne Skerra
Jun 24, 2009·Biotechnology and Applied Biochemistry·Andreas JonssonFredrik Y Frejd
Jun 6, 2009·Biotechnology and Applied Biochemistry·Mikaela FriedmanStefan Ståhl
Dec 18, 2009·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Jun 19, 2015·Bioconjugate Chemistry·Kristina WesterlundAmelie Eriksson Karlström
Jun 19, 2014·International Journal of Pharmaceutics·Amreddy NarsireddyNalam M Rao
Jul 6, 2011·Current Opinion in Biotechnology·John LöfblomStefan Ståhl
Mar 19, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jacob O FiererMark Howarth
Jul 6, 2016·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Ana Luiza Ribeiro de SouzaBrian W Pogue
Nov 23, 2016·Scientific Reports·Abdulkarim M AlsultanStephen M Mahler
Dec 3, 2016·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Kimberley S SamkoeBrian W Pogue
Jan 1, 2010·Biotechnology & Genetic Engineering Reviews·R Cochran, Frank Cochran
Mar 25, 2017·Experimental & Molecular Medicine·Fredrik Y Frejd, Kyu-Tae Kim
Sep 17, 2013·Biotechnology and Applied Biochemistry·Helena Wållberg, Stefan Ståhl
Nov 26, 2009·Natural Product Reports·Matthew F Burton, Patrick G Steel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.